Skip to content

Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications

Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01511094
Acronym
GC
Enrollment
32
Registered
2012-01-18
Start date
2009-06-30
Completion date
2012-01-31
Last updated
2012-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open-Angle Glaucoma, Surgery

Keywords

ab-interno trabeculectomy,, intraocular pressure,, open angle glaucoma, trabeculectomy, Goniocurettage, Non-Filtering Surgery

Brief summary

The study has the purpose to evaluate the effectiveness and safety of the goniocurettage as a first choice of surgical treatment for primary open-angle glaucoma (POAG) in patients with good vision.

Detailed description

A prospective study in 33 eyes (32 patients) with uncontrolled open angle glaucoma under clinical treatment. The trabecular tissue was scraped away from the angle (goniocurettage) in about 100 degrees by means of an instrument similar to a microchalazion curette. The goniocurettage was done under direct visualization of the angle through a gonioscopy lens (Swan-Jacob) and a surgical microscope. Using the 17.0 SPSS software the investigators compared the intraocular pressure, the numbers of antiglaucomatous medications, the best correct visual acuity, the development of cataract, the central corneal thickness,the impact on the visual field, the impact on the optic nerve head and the central corneal endothelial cell density before and after the goniocurettage, and the intra and post operative complications.

Interventions

PROCEDUREGoniocurettage

Ab interno surgery consisting on scraped away the trabecular tissue from the angle (goniocurettage) removing segments of pathologically altered trabecular meshwork from the scleral sulcus

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Disc and/or visual field findings consistent with Primary Open Angle Glaucoma * Uncontrolled intraocular pressure (≥21 mm Hg) or progressive glaucomatous neuropathy despite maximum tolerated medical therapy * 40 years old or over * Visual acuity higher than 0.2 * Open angles (greater or equal to Shaffer grade II)

Exclusion criteria

* Previous ocular surgery * History of glaucoma laser treatment * History of ocular trauma * Cyclodestructive procedures * Corneal edema or opacities * Endothelial decompensation * History of uveitis * Secondary glaucoma * neovascularization of the iris or angle * Congenital anterior segment abnormalities * Anatomically confusing angles without clear definition of the scleral spur or meshwork and inability to maintain follow-up

Design outcomes

Primary

MeasureTime frameDescription
Intra Ocular PressureChange from Baseline in Intra Ocular Pressure at 20 monthsThe mean of at least three measures at 8:00 am two weeks before surgery. After intervention, the Intra Ocular Pressure was measured on the day after, one week after, two weeks after and every month at the same time until the end of the study (an expected average of 20 months).

Secondary

MeasureTime frame
Central Corneal ThicknessTwo weeks before, six months after and one year after intervention
Central corneal endothelial cell densityTwo weeks before, six months after intervention and one year after intervention
Best correct visual acuityTwo weeks before, six months after and one year after intervention

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026